ClinicalTrials.gov
ClinicalTrials.gov Menu

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00791271
Recruitment Status : Completed
First Posted : November 14, 2008
Last Update Posted : November 16, 2015
Sponsor:
Collaborators:
Schering-Plough
Eisai Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2015
  Actual Study Completion Date : May 2015